Abstract
<h3>To the Editor.—</h3> The recent article by Nademanee and Singh (1982;247:217) did not emphasize the significant potential adverse reactions that we have noted in 100 patients receiving a mean dosage of 461 mg/day of amiodarone hydrochloride. Transient ischemic attacks have occurred in four of our patients and cerebral vascular accidents have occurred in three patients after initiation of amiodarone therapy (followup, one to 20 months; mean, 6.6 months). While our patients have a high incidence of vascular disease, only five patients had cerebral vascular accidents before the initiation of amiodarone therapy. We hope that this will not prove to be a long-term sequelae of amiodarone therapy. Weakness, fatigue, a nonproductive cough, and dyspnea have been symptoms that have responded to diuresis. None of our patients required cessation of therapy because of the adult respiratory distress syndrome. We have reported previously<sup>1</sup>a grading system for amiodarone keratopathy. However, we neglected to
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
